News

  1. Oct. 18, 2019

    Updates in interstitial lung disease: Current facets of anti-fibrotic therapy

    Teng Moua, M.D., discusses recent clinical trials and current research into the treatment of idiopathic pulmonary fibrosis (IPF) and non-IPF-progressive interstitial lung diseases.

  2. Oct. 15, 2019

    Pediatric sleep medicine integrates with multidisciplinary clinics to facilitate communication and treatment

    Mayo Clinic's Center for Sleep Medicine team provides multidisciplinary care for children in special populations or with medically complex needs.

  3. Oct. 15, 2019

    Advancing care in chronic obstructive pulmonary disease

    Mayo Clinic's home-based pulmonary rehabilitation program provides patients who have chronic obstructive pulmonary disease (COPD) with a health coach and a computer-guided activity and monitoring program.

  4. Oct. 15, 2019

    Ion robotic bronchoscopy system the focus of a multicenter trial

    Mayo Clinic has joined five other medical centers to conduct a multicenter trial, enrolling 300 patients to prospectively evaluate the use of a robotic bronchoscopy system.

  5. Oct. 15, 2019

    Management of fibrosing mediastinitis

    Specialists at Mayo Clinic have used off-label rituximab to treat nearly 30 patients with fibrosing mediastinitis successfully. Disease progression was almost universally halted and two-thirds of the patients improved s[...]

  6. April 19, 2019

    Bronchoscopic lung volume reduction therapy approved for severe emphysema

    Bronchoscopic lung volume reduction has emerged as a potential alternative to lung volume reduction surgery and a less invasive method by which to achieve lung volume reduction in patients with emphysema and hyperinflat[...]

  7. Jan. 11, 2019

    Update on the management of ANCA-associated vasculitis

    Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis comprises three syndromes, all with frequent respiratory manifestations. Studies indicate that ANCA specificity is more important for prognosis, relapse [...]

  8. Jan. 08, 2019

    Multidisciplinary care of idiopathic subglottic stenosis

    A combined approach of inhaled glucocorticoids, trimethoprim-sulfamethoxazole, and proton-pump inhibitors plus lifestyle modifications for the treatment of idiopathic subglottic stenosis (ISS) suggests that ISS recurs l[...]

  9. Jan. 08, 2019

    Update in pleural disease

    This update addresses some of the latest understanding and approaches to management of malignant pleural disease, including use of the RAPID multistep scoring system to better predict prognosis in those patients who pre[...]

  10. Jan. 08, 2019

    Cone-beam CT for enhanced bronchoscopic access to pulmonary nodules

    Interventional pulmonologists and thoracic surgeons are exploring the use of cone-beam CT during bronchoscopy. Cone-beam CT image quality is sufficient for localizing pulmonary nodules, with the added benefit of real-ti[...]

  11. Jan. 08, 2019

    Anti-interleukin-5 therapy for severe asthma: A new therapeutic option

    Anti-interleukin-5 therapy is approved for patients with refractory asthma with an eosinophilic phenotype. The severe asthma care team at Mayo Clinic has expertise in identifying appropriate patients for this step-up th[...]

  12. Sept. 18, 2018

    New technology overcomes false-positives in CT for lung cancer

    Mayo researchers find that radiomics technology may help overcome false-positives in CT-based lung cancer screening: Mayo Clinic Forefront cancer magazine.

  13. Sept. 12, 2018

    New definitions and diagnoses in interstitial pneumonia

    While interstitial pneumonias have been studied and recognized over several decades, a new classification system provides a more intuitive organization of both the prevalence and natural course of specific histologic pa[...]

  14. Sept. 12, 2018

    Lung transplantation: Challenges and opportunities

    Mayo Clinic and United Therapeutics Corp. are furthering the study of ex vivo lung perfusion and ventilation to resuscitate and support donor lungs that would otherwise be unavailable for transplant.

  15. Sept. 12, 2018

    Anti-fibrotic therapy in the treatment of IPF: Ongoing concerns and current practices

    Pirfenidone and nintedanib are approved for treatment of idiopathic pulmonary fibrosis (IPF), but questions remain regarding indications and timing of initiation, side effects, and long-term outcomes.

  16. Feb. 10, 2018

    Maxillomandibular advancement surgery: A classic procedure refined

    MMA should be considered for any patient with moderate to severe obstructive sleep apnea if surgical management is desired. At Mayo Clinic, more than half of patients with obstructive sleep apnea achieve elimination (ap[...]

  17. Feb. 10, 2018

    The gaining popularity of oral appliances

    Oral appliances can improve important outcomes in selected patients with more severe obstructive sleep apnea (OSA). Innovations include compliance recorders to help in long-term follow-up and emerging technologies to re[...]

  18. Feb. 10, 2018

    The emerging option of upper airway stimulation therapy

    Activation of the genioglossus muscle via stimulation of the hypoglossal nerve is a new approach for treatment of obstructive sleep apnea (OSA). In a 2014 study, stimulation was associated with a 68 percent reduction in[...]

  19. Feb. 09, 2018

    Care of the patient with lung cancer at Mayo Clinic: Mayo Clinic tumor board provides multidisciplinary expertise

    The multidisciplinary assembly provides up-to-date treatment options for patients with lung cancer, explores enrollment in clinical trials, and enhances cross-discipline education from the exchange of information and ex[...]

  20. Feb. 09, 2018

    Advances in lung cancer immunotherapy and management of immune-mediated adverse events

    A new study explores the combination of the intratumoral administration of the measles virus with systemic PD-L1 targeted immunotherapy using atezolizumab for second line therapy of non-small cell lung cancer.

  21. Jan. 20, 2018

    Noninvasive radiologic biomarkers to individualize lung cancer therapy

    Computer-Aided Nodule Assessment and Risk Yield (CANARY) image analysis software has shown promise in noninvasively predicting epithelial growth factor receptor (EGFR) status of adenocarcinoma of the lung, allowing for [...]

  22. Feb. 26, 2016

    Transbronchial cryobiopsy in diffuse parenchymal lung disease

    Mayo pulmonary specialists have evaluated the use of cryobiopsies in selected patients with diffuse parenchymal lung diseases for several years. Advantages include the ability to collect much larger specimens while pres[...]

  23. Jan. 22, 2016

    Advancements in localization of peripheral pulmonary nodules for diagnosis and treatment

    Collaboration between interventional pulmonology, radiation oncology and thoracic surgery specialists has resulted in successful localization and management of pulmonary nodules smaller than 1 centimeter.

  24. May 30, 2015

    Pulmonary vascular complications of chronic liver disease

    Mayo pulmonologists with expertise in the management of portopulmonary hypertension (POPH) and hepatopulmonary syndrome (HPS) help care for patients with chronic liver disease secondary to cirrhosis.

  25. March 28, 2015

    Alpha-1-antitrypsin deficiency: A liver-lung connection

    Alpha-1-antitrypsin (AAt) deficiency is an inherited disorder that results in liver disease, lung disease or both. Patients with liver dysfunction and early-stage chronic obstructive lung disease or asthma that does not[...]

  26. March 03, 2015

    Mayo Clinic's Cystic Fibrosis Foundation-designated CF care center

    Mayo's Cystic Fibrosis Center specializes in the care of pediatric and adult patients - Cystic fibrosis is the most common genetic disease of Caucasians. Expected survival has increased to 38-plus years, thanks to adher[...]